Basic information
- Name:
1H-Purine-2,6-dione,7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-
- Superlist Name:
- Doxofylline
- CAS No.:
69975-86-6
- Molecular Structure:

- Formula:
- C11H14N4O4
- Molecular Weight:
- 266.29
- Synonyms:
- Theophylline,7-(1,3-dioxolan-2-ylmethyl)- (7CI);2-(7'-Theophyllinemethyl)-1,3-dioxolane;ABC 12/3;ABC 1213;Ansimar;Dioxyfilline;Doxophylline;Maxivent;Ventax;1H-purine-2,6-dione, 7-(1,3-dioxolan-2-ylmethyl)-3,7-dihydro-1,3-dimethyl-;7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione;
- EINECS:
- 274-239-6
- Density:
- 1.59 g/cm3
- Melting Point:
- 144-146 °C
- Boiling Point:
- 505.2 °C at 760 mmHg
- Flash Point:
- 259.3 °C
- Solubility:
- soluble in water
- Hazard Symbols:
Xi- Risk Codes:
- 36/37/38
- Safety Description:
- 26-36/37 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Specification
The Doxofylline, with the CAS registry number 69975-86-6 and EINECS registry number 274-239-6, has the systematic name of 7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione. It is a xanthine derivative drug used in the treatment of asthma. The molecular formula of this chemical is C11H14N4O4.
The physical properties of Doxofylline are as following: (1)ACD/LogP: -0.70; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.7; (4)ACD/LogD (pH 7.4): -0.7; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 9.89; (8)ACD/KOC (pH 7.4): 9.89; (9)#H bond acceptors: 8; (10)#H bond donors: 0; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 76.9 Å2; (13)Index of Refraction: 1.7; (14)Molar Refractivity: 64.62 cm3; (15)Molar Volume: 167.1 cm3; (16)Polarizability: 25.61×10-24cm3; (17)Surface Tension: 63.3 dyne/cm; (18)Density: 1.59 g/cm3; (19)Flash Point: 259.3 °C; (20)Enthalpy of Vaporization: 77.48 kJ/mol; (21)Boiling Point: 505.2 °C at 760 mmHg; (22)Vapour Pressure: 2.49E-10 mmHg at 25°C.
Preparation of Doxofylline: Dissolve theophylline in the hot water, add sodium hydroxide and 3-chloro 1,2-propanediol, and reflux the silution. Recrystallize it with etahol, and the result is compound (I). Dissolve the compound (I) in water, add equimolar HIO4.2H2O with stir, filter and recrystallize, and the rusult is theophylline acetaldehyde. Reflux theophylline acetaldehyde, ethylene glycol and p-toluenesulfonate in benzene, and the result is Doxofylline.
You should be cautious while dealing with this chemical. It irritates eyes, respiratory system and skin. Therefore, you had better take the following instructions: Wear suitable protective clothing and gloves, and in case of contacting with eyes, rinse immediately with plenty of water and seek medical advice.
You can still convert the following datas into molecular structure:
(1)SMILES: O=C2c1n(cnc1N(C(=O)N2C)C)CC3OCCO3
(2)InChI: InChI=1/C11H14N4O4/c1-13-9-8(10(16)14(2)11(13)17)15(6-12-9)5-7-18-3-4-19-7/h6-7H,3-5H2,1-2H3
(3)InChIKey: HWXIGFIVGWUZAO-UHFFFAOYAA
The toxicity data is as follows:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 396mg/kg (396mg/kg) | United States Patent Document. Vol. #4187308, | |
| mouse | LD50 | intravenous | 216mg/kg (216mg/kg) | Farmaco, Edizione Scientifica. Vol. 36, Pg. 201, 1981. | |
| mouse | LD50 | oral | 841mg/kg (841mg/kg) | Farmaco, Edizione Scientifica. Vol. 36, Pg. 201, 1981. | |
| rat | LD50 | intraperitoneal | 426mg/kg (426mg/kg) | United States Patent Document. Vol. #4187308, | |
| rat | LD50 | intravenous | 315mg/kg (315mg/kg) | United States Patent Document. Vol. #4187308, | |
| rat | LD50 | oral | 965mg/kg (965mg/kg) | United States Patent Document. Vol. #4868186, |

